Background: Laparoscopic sleeve gastrectomy (LSG) is currently the most frequently
performed bariatric procedure in Turkey. The goal of weight reduction
surgery is not only to decrease excess weight, but also to improve obesity
related comorbidities and quality of life (QoL). Aim: To evaluate the impact of LSG on patient quality of life, weight loss, and
comorbidities associated with morbid obesity according to the updated BAROS
criteria. Methods: Eleven hundred thirty-eight adult patients were undergone to LSG by our
bariatric surgery team between January 2013 and January 2016. A
questionnaire (The Bariatric Analysis and Reporting Outcome System - BAROS)
was published on social media. The data on postoperative complications were
collected from hospital database. Results: Number of respondants was 562 (49.4%). Six of 1138 patients(0.5%) had
leakage. All patients who had leakage were respondants. The overall
complication rate was 7.7%. After a mean period of 7.4±5.3 months(1-30),
mean excess weight loss was 71.3±27.1% (10.2-155.4). The respondants
reported 772 comorbidities. Of these, 162 (30%) were improved, and 420
(54.4%) were resolved. The mean scores for QoL were significantly increased
after LSG (range, p<0.05 to <0.001). Of the 562 patients, 26 (4.6%)
were classified as failures; 86 (15.3%) fair; 196 (34.9%) good; 144 (25.6%)
very good, and 110 (19.6%) excellent results according to the updated BAROS
scoring system. Conclusion: LSG is a highly effective bariatric procedure in the manner of weight
control, improvement in comorbidities and increasing of QoL in short- and
mid-term.
Background:
The purpose of this study is to identify lesions in the esophagus, stomach and duodenal bulb in patients with AIDS through endoscopy, and to correlate the results obtained with the histophatological study of standardized endoscopic biopsies of the esophagus, stomach and duodenal bulb.
Methods:
Eight standardized endoscopic biopsies were taken at every endoscopic examination: two from the distal segment of the esophagus, two from the body of the stomach, two from the gastric antrum and two from the duodenal bulb. The biopsies specimens were stained with H&E, Ziehl‐Nielsen‐Faraco, Giemsa and periodic acid‐schiff dyes. The avidin‐biotin‐peroxidase method was used for the immunohistochemical study.
Results:
Endoscopy with standardized endoscopic biopsies of the upper gastrointestinal tract in patients with AIDS demonstrated specific findings in the esophagus at 24.1% of cases, 16.1% in the stomach and 8.0% in the duodenal bulb. Endoscopy with standardized endoscopic biopsies of the gastrointestinal tract in patients with AIDS, even with normal endoscopic appearance, displayed specific findings in the stomach at 27.7% and in the duodenal bulb at 27.7%.
Conclusion:
Quite often, the endoscopic features in the esophagus, stomach and duodenal bulb in patients with AIDS do not appear to be associated with pathogens identified in them. Although we do not have data at this time, this series opens the discussion and shows that, even in patients with AIDS presenting a normal endoscopic finding, performing standardized endoscopic biopsies for the detection of opportunistic infections in various segments of the gastrointestinal tract could be very important.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.